Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections
Access

26 - 50 of 198 Items

Original paper2024, dec 5
Review paper2024, dec 5

The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy

Mariusz Nowak, Wojciech Nowak, Bogdan Marek, Beata Kos-Kudła, Lucyna Siemińska, Magdalena Londzin-Olesik, Dariusz Kajdaniuk

Vol 75, No 6 (2024)

Review paper

Pubmed: 40091323
Endokrynol Pol 2024;75(6):604-616.
Original paper2024, dec 3

The role and diagnostics of miR-181d-5p in polycystic ovary syndrome in insulin-resistant women

Min Sang, Ying Yu, Yaqi Zhang, Haiping Chang

Vol 75, No 6 (2024)

Original paper

Pubmed: 40091327
Endokrynol Pol 2024;75(6):655-664.
Clinical vignette2024, dec 3

Are ovarian cysts a coincidence after treatment for Van Wyk-Grumbach syndrome?

Haiying Fang, Hongxian Lv, Huiqin Wang, Linqian Zhang

Vol 75, No 6 (2024)

Clinical vignette

Pubmed: 40091332
Endokrynol Pol 2024;75(6):695-696.
Clinical vignette2024, nov 26
Clinical vignette2024, nov 26

Pasireotide treatment in giant prolactinoma resistant to dopamine agonists

Maria Komisarz-Calik, Grzegorz Zieliński, Karol Ciszek, Anna Bogusławska, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 75, No 6 (2024)

Clinical vignette

Pubmed: 40091333
Endokrynol Pol 2024;75(6):697-698.
Original paper2024, nov 26

Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms

Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Anna Drozd, Gabriela Różańska-Grzelak, Katarzyna Janiak, Dorota Brodowska-Kania, Grzegorz Kamiński

Vol 75, No 6 (2024)

Original paper

Pubmed: 40091328
Endokrynol Pol 2024;75(6):665-671.
Review paper2024, nov 26

Novel radiopharmaceuticals in endocrinology: a comprehensive review

Mateusz Pocięgiel, Tomasz Saniewski, Kamil Wrzosek, Piotr Opyd, Edward Franek, Michał Lis

Vol 75, No 6 (2024)

Review paper

Pubmed: 39829215
Endokrynol Pol 2024;75(6):617-629.
Clinical vignette2024, nov 25

Clinical outcomes and long-term follow-up after radioligand therapy in aggressive non-functioning pituitary neuroendocrine tumour

Dorota Brodowska-Kania, Marek Saracyn, Natalia Osial, Adam Daniel Durma, Maciej Kołodziej, Grzegorz Kamiński

Vol 75, No 6 (2024)

Clinical vignette

Pubmed: 40091331
Endokrynol Pol 2024;75(6):693-694.
Original paper2024, oct 29

Identification of fibrosis-associated lncRNAs in diabetic cardiomyopathy patients

Xiyan Dai, Dongping Chen, Fan Yang, Zhihui Dong, Lu Yang, Jiading He, Jianmin Xiao

Vol 75, No 5 (2024)

Original paper

Pubmed: 39475132
Endokrynol Pol 2024;75(5):525-538.
Review paper2024, oct 29
Clinical vignette2024, oct 18

Simultaneous occurrence of thyroblastoma and papillary carcinoma

Yixuan Chen, Wei An

Vol 75, No 5 (2024)

Clinical vignette

Pubmed: 39475136
Endokrynol Pol 2024;75(5):562-536.
Original paper2024, oct 18

Recurrence patterns in differentiated thyroid cancer (DTC) following adjuvant radioiodine therapy

Aleksandra Ledwon, Aleksandra Kropińska, Ewa Paliczka-Cieślik, Aleksandra Blewąska, Aleksandra Syguła, Tomasz Olczyk, Daria Handkiewicz-Junak

Vol 75, No 5 (2024)

Original paper

Pubmed: 39475131
Endokrynol Pol 2024;75(5):486-493.
Review paper2024, oct 18

Autoimmune thyroiditis: an update on treatment possibilities

Kamil Dyrka, Monika Obara-Moszyńska, Marek Niedziela

Vol 75, No 5 (2024)

Review paper

Pubmed: 39475129
Endokrynol Pol 2024;75(5):461-472.
Original paper2024, oct 18

An analysis of acid-labile subunit (ALS) levels in children with short stature born with normal weight

Tomasz Jackowski, Anita Horodnicka-Józwa, Ewa Berus, Mieczysław Walczak, Elżbieta Petriczko

Vol 75, No 5 (2024)

Original paper

Pubmed: 39475135
Endokrynol Pol 2024;75(5):548-557.
Original paper2024, oct 18

Falls in RAC-OST-POL Study: the results from 10-year prospective longitudinal observation

Wojciech Pluskiewicz, Piotr Adamczyk, Bogna Drozdzowska

Vol 75, No 5 (2024)

Original paper

Pubmed: 39475134
Endokrynol Pol 2024;75(5):543-547.
Original paper2024, oct 18
Original paper2024, oct 8

Correlation analysis of FT3/FT4 and frailty in elderly patients with coronary heart disease

Jiling Qu, Siqi Ji, Ting Zhou, Chuntao Wang, Yongbing Liu

Vol 75, No 5 (2024)

Original paper

Pubmed: 39376178
Endokrynol Pol 2024;75(5):510-516.
Original paper2024, oct 7
Original paper2024, oct 7
Clinical vignette2024, oct 7

Adrenal hypoplasia congenita and hypogonadotropic hypogonadism due to a novel NR0B1 (DAX1) gene mutation associated with common variable immunodeficiency and Hashimoto’s thyroiditis

Jasmina Ćirić, Ivana Novaković, Aleksandra Perić‐Popadić, Miloš Žarković, Biljana Nedeljković Beleslin, Branka Bonači-Nikolić

Vol 75, No 5 (2024)

Clinical vignette

Pubmed: 39376180
Endokrynol Pol 2024;75(5):560-561.
Clinical vignette2024, oct 3
Review paper2024, sep 27

Polycystic ovary syndrome and type 1 diabetes — the current state of knowledge

Edyta Cichocka, Anna Maj-Podsiadło, Janusz Gumprecht

Vol 75, No 5 (2024)

Review paper

Pubmed: 39376174
Endokrynol Pol 2024;75(5):479-485.
Review paper2024, sep 23

Thyroid cancer and autoimmune connective tissue disorders

Maria Aleksandra Komisarz-Calik, Alicja Hubalewska-Dydejczyk, Bogdan Batko, Małgorzata Trofimiuk-Müldner

Vol 75, No 5 (2024)

Review paper

Pubmed: 39376173
Endokrynol Pol 2024;75(5):455-460.
Original paper2024, sep 11

Feasibility study of lncRNA DHRS4-AS1 sponge miR-222-3p in the diagnosis of thyroid cancer

Shuai Xu, Xinyi Zheng, Haibin Wu, Xujun You, Junwei Wu, Hai Zhou, Junhua Wu, Qianqian Liu, Ren-qun Ye

Vol 75, No 5 (2024)

Original paper

Pubmed: 39376175
Endokrynol Pol 2024;75(5):494-500.